SEPCELL Trial Investigator Meeting October 18th, Madrid, Spain.
The SEPCELL trial Investigator Meeting took place in Madrid, Spain, on October 18th organized by TiGenix and with the participation of the SEPCELL national coordinators Dr François, Dr Laterre, Dr Sánchez and Dr van der Poll.
Over thirty clinical investigators and study coordinators attended the meeting, in which the members of the consortium shared further insights on the rationale of using mesenchymal stem cells to treat sepsis, extensively presented the clinical trial protocol, and discussed practical clinical cases for patient selection as well as different logistics and methodological aspects of the study.
We are looking forward to announcing the recruitment of the first patient in due course.
Dr. Laterre and Dr. Sánchez during the Investigator Meeting in Madrid
Over 30 clinical investigators attended the meeting